Sichuan Elixir Pharmaceutical is an API manufacturer based in China. It holds 13 active US drug master files across a filed portfolio of 12 molecules. Its filings concentrate with EFDA (ET), NAFDAC (NG) and SFDA (Saudi Arabia). Its GMP standing is certified by NAFDAC (NG) and FDA (GH).
| Site | FDA FEI |
|---|---|
| Nani Daman, Nigeria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Cabozantinib | US FDA | 2 |
| Abemaciclib | US FDA | 1 |
| Cabazitaxel | US FDA | 1 |
| Cytisine | US FDA | 1 |
| Darolutamide | US FDA | 1 |
| Dasatinib | US FDA | 1 |
| Indigotindisulfonate Sodium | US FDA | 1 |
| Methotrexate | US FDA | 1 |
| Nilotinib | US FDA | 1 |
| Resmetirom | US FDA | 1 |
| Sn-38 | US FDA | 1 |
| Ursodeoxycholic Acid | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EFDA (ET) | 44 | None |
| NAFDAC (NG) | 34 | 3 |
| SFDA (Saudi Arabia) | 9 | None |
| FDA (GH) | 8 | 1 |
| ZAMRA (ZM) | 3 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Sichuan Elixir Pharmaceutical, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.